Clinical Trials
5 trialsNCT03625323 2026-04-22
TACTI-002
Immutep S.A.S.
Phase 2 Completed
NCT04811027 2025-12-11
TACTI-003
Immutep S.A.S.
Phase 2 Completed
NCT02676869 2019-12-18
TACTI-mel
Immutep Australia Pty. Ltd.
Phase 1 Completed
NCT00349934 2010-01-07
IMP321 Plus First-line Paclitaxel in Metastatic Breast Carcinoma
Immutep S.A.S.
Phase 1 Completed
NCT00351949 2010-01-07
IMP321 Phase 1 Trial in Metastatic Renal Cell Carcinoma (MRCC)
Immutep S.A.S.
Phase 1 Completed